VIC Foundry Awarded Phase I SBIR Grant from the National Institutes of Health
NIH Grant is to Develop a Portable Sample Preparation Device for Concentration and Recovery of Bacterial Contaminants
Direct-to-Phase II SBIR Grant from NIH Awarded to Neurexis Therapeutics to Evaluate Neuroprotective Therapeutic in Stroke Preclinical Assessment Network (SPAN)
A promising approach for preventing cognitive and behavioral impairment following ischemia Aurora, CO - Neurexis Therapeutics, Incorporated, announces it has been awarded $900,000 in funding from a Direct-to-Phase II...
Solaris Vaccines Adds Izabela Ragan as Director of Research and Development for the SolaVAX™ Platform
FORT COLLINS, CO – Solaris Vaccines, Inc. announced today that Dr. Izabela Ragan (DVM, PhD), an expert in novel vaccine technologies, has joined as Director of Research and Development. The Company is developing a...
Intellectual Property Landscape Analysis Using Free Patent Databases
For an investor seeking a decision on whether or not to invest in an innovation-based startup, there are numerous factors they need to take into consideration. Some of the most important questions that need to be...
Due Diligence for Life Science Investments
Investing in a life science startup can be a lucrative opportunity, but it requires careful evaluation to weigh the potential reward against the level of risk. Members of VIC Tech's affiliated VIC Investor Network...
From the Corner Office: Michael Artinger, PhD – CEO of Solaris Vaccines, Inc.
I have been very fortunate to have had a varied and diverse career accelerating the development of life science innovation, including therapeutics, vaccines, medical devices, diagnostics, analytical instruments,...
Cellia Science Awarded National Institutes of Health Phase I SBIR Funding
Fayetteville, AR - Cellia Science, a point-of-care hematology company, announced today that it has been awarded a Small Business Innovation Research (SBIR) Phase I grant from the National Heart, Lung, and Blood...
VIC Fellows Spotlight: Matthew Leming, PhD
The VIC Fellows Program provides an opportunity for individuals with relevant expertise and interest to learn how to identify and evaluate promising innovations from global sources. We are pleased to highlight the...
VIC 2022 Annual Report Executive Summary
2022 was a highly productive year for VIC and our portfolio companies. Click Here to download the Annual Report Executive Summary or view it below.
VIC Tech Adds Chantell Preston to Board of Directors
Bringing a proven track record in healthcare operations, innovation, and investing. FAYETTEVILLE, AR- VIC Technology Venture Development is pleased to announce the appointment of Chantell Preston, who brings 20+ years...
